Haleos Labs Limited

HALEOSLABS

Watchlist

AI Mode

‌

Market Cap

₹ 422 Cr

P/E

22.59

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bullish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

SMS Lifesciences India Limited is primarily involved in the manufacturing and export of Active Pharmaceutical Ingredients (APIs) and their intermediates. The company operates multiple facilities across Hyderabad.

Originally incorporated as a real estate private limited company in 2006, SMS Lifesciences has undergone several transformations, including demergers and acquisitions.

The company holds significant recognition as an export house since 1997, indicating expertise in global pharmaceutical supply chains.

With three multi-product facilities and a research center, SMS Lifesciences engages in contract manufacturing and research assignments for an international clientele.

A strategic demerger in 2017 positioned the company to leverage semi-regulated units, enhancing its manufacturing capabilities and international market reach.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

422 Cr

Volatility

High Risk

P/E Ratio

22.6

Industry P/E

30.8

PEG Ratio

0.1

P/B Ratio

2.1

52W High

1,680.00

52W Low

956.05

Sales CAGR

12.67%

-0.96%

5.44%

10Y

—

Profit CAGR

195.89%

-5.57%

18.50%

10Y

—

ROE

TTM

9.06%

8.87%

10.58%

10Y

10.92%

ROCE

TTM

12.31%

13.04%

14.43%

10Y

15.01%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
NECLIFE	21.20	471 Cr	—	0.66	0.00	-17.19	-12.07	-19.92
ALBERTDAVD	747.60	429 Cr	—	1.09	0.66	-3.83	-3.33	-2.83
HALEOSLABS	1389.20	422 Cr	22.59	2.05	0.11	9.06	12.31	4.86
MEDICO	49.83	418 Cr	36.74	6.25	0.00	16.97	20.65	8.26
AMANTA	104.00	406 Cr	29.07	1.93	0.00	6.64	11.47	2.73
FABCLEAN	302.00	377 Cr	28.54	4.00	0.65	12.57	13.83	7.53
VALIANTLAB	66.82	360 Cr	71.32	1.14	0.00	1.60	1.50	1.19

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	75	69	72	90	93	78	85	89	83	81
Expenses	72	61	63	79	76	70	72	82	71	68
Operating Profit	2.53	7.92	9.29	11	16	8.56	13	7.42	12	14
OPM %	3.39	11.44	12.89	12.62	17.60	10.91	15.08	8.33	14.19	16.69
Other Income	0.61	0.27	0.58	2.36	0.44	2.04	0.06	2.34	1.00	0.42
Interest	2.18	2.81	2.34	2.84	2.40	2.14	2.14	2.03	1.87	1.62
Depreciation	3.70	3.73	3.73	3.78	3.68	3.76	3.76	3.80	3.82	3.89
Profit Before Tax	-2.73	1.66	3.81	7.10	11	4.70	6.92	3.93	7.02	8.49
Tax %	-40.29	126.51	-8.14	8.87	33.27	29.79	29.77	11.45	37.61	24.38
Net Profit	-3.83	-0.44	4.12	6.47	7.10	3.30	4.85	3.48	4.38	6.43
EPS in Rs	-5.94	2.20	14.24	19.53	23.15	15.46	18.08	9.83	13.75	20.19

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	416	291	295	389	358	339	386	335
Expenses	343	235	235	316	287	275	300	294
Operating Profit	73	55	60	73	71	64	86	40
OPM %	17.60	18.98	20.24	18.81	19.92	18.93	22.35	12.09
Other Income	2.55	2.28	1.78	14	5.42	3.83	4.86	5.44
Interest	5.51	5.14	4.53	6.17	6.79	10	8.71	8.18
Depreciation	6.38	7.86	7.86	10	11	15	15	15
Profit Before Tax	25	15	20	33	17	9.85	26	23
Tax %	29.69	30.58	30.72	22.70	31.43	35.74	28.47	29.07
Net Profit	18	10	14	25	11	6.33	19	16
EPS in Rs	—	31.87	44.81	79.61	30.51	30.03	66.52	61.85
Dividend Payout %	2.54	0.00	3.35	1.79	3.96	4.99	2.26	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.02	3.02	3.02	3.02	3.02	3.02	3.02
Reserves	103	113	126	149	166	174	194
Borrowings	40	59	65	80	100	101	86
Other Liabilities	124	78	108	125	126	113	107
Total Liabilities	270	253	302	357	395	391	390
Fixed Assets	118	124	130	142	228	223	232
CWIP	3.29	16	38	51	0.85	6.00	0.40
Investments	0.95	0.04	0.04	0.04	0.04	0.04	0.04
Other Assets	148	113	134	163	166	161	158
Total Assets	270	253	302	357	395	391	390

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	30	15	35	-11	15	24	34
Cash from Investing Activity	-44	-27	-26	-7.14	-31	-18	-15
Cash from Financing Activity	15	12	-2.55	11	17	-6.56	-19
Net Cash Flow	1.35	-0.03	6.39	-7.55	0.29	-0.71	-0.07

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	70.32%	70.32%	70.32%	70.32%	70.68%	71.19%	71.41%	71.41%	71.41%	71.41%	71.41%	71.41%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.02%	0.00%	0.00%	0.03%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%
Public	29.68%	29.68%	29.68%	29.68%	29.32%	28.81%	28.58%	28.57%	28.59%	28.59%	28.56%	28.57%
Total Shareholders	8,593	8,349	8,475	8,443	8,233	8,116	7,861	7,849	7,626	7,479	7,412	7,521

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Mar 19, 2025	Tv praveen	Insider - Promoter Group	Acquisition	1,062.15	12.81 Cr	1,20,595	3.98
Mar 19, 2025	Sudeepthi gopineedi	Insider - Promoter Group	Acquisition	1,062.15	12.81 Cr	1,20,595	3.98
Mar 19, 2025	Tvvsn murthy huf	Insider - Promoter	Disposal	1,062.15	25.62 Cr	2,41,190	7.98
Aug 12, 2024	Saibabu bandla	Bulk	Sell	1,356.20	2.71 Cr	20,000	0.66
Jul 01, 2024	Tv praveen	Insider - Promoter Group	Acquisition	826.80	0.53 Cr	6,367	0.21
Apr 25, 2024	Suresh babu potluri	Insider - Other	Disposal	713.96	0.22 Cr	3,101	0.1
Mar 29, 2024	Tv praveen	Insider - Promoter Group	Acquisition	645.31	1.00 Cr	15,443	0.51
Dec 30, 2023	Tv praveen	Insider - Promoter Group	Acquisition	541.33	0.59 Cr	10,949	0.36
Dec 28, 2023	Sudeepthi gopineedi	Insider - Promoter Group	Disposal	516.94	0.42 Cr	8,119	0.26
Dec 28, 2023	Tv praveen	Insider - Promoter Group	Acquisition	516.94	0.42 Cr	8,119	0.26

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Oscillators

BearishNeutralBullish

Neutral

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	75	69	72	90	93	78	85	89	83	81
Expenses	72	61	63	79	76	70	72	82	71	68
Operating Profit	2.53	7.92	9.29	11	16	8.56	13	7.42	12	14
OPM %	3.39	11.44	12.89	12.62	17.60	10.91	15.08	8.33	14.19	16.69
Other Income	0.61	0.27	0.58	2.36	0.44	2.04	0.06	2.34	1.00	0.42
Interest	2.18	2.81	2.34	2.84	2.40	2.14	2.14	2.03	1.87	1.62
Depreciation	3.70	3.73	3.73	3.78	3.68	3.76	3.76	3.80	3.82	3.89
Profit Before Tax	-2.73	1.66	3.81	7.10	11	4.70	6.92	3.93	7.02	8.49
Tax %	-40.29	126.51	-8.14	8.87	33.27	29.79	29.77	11.45	37.61	24.38
Net Profit	-3.83	-0.44	4.12	6.47	7.10	3.30	4.85	3.48	4.38	6.43
EPS in Rs	-5.94	2.20	14.24	19.53	23.15	15.46	18.08	9.83	13.75	20.19

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	416	291	295	389	358	339	386	335
Expenses	343	235	235	316	287	275	300	294
Operating Profit	73	55	60	73	71	64	86	40
OPM %	17.60	18.98	20.24	18.81	19.92	18.93	22.35	12.09
Other Income	2.55	2.28	1.78	14	5.42	3.83	4.86	5.44
Interest	5.51	5.14	4.53	6.17	6.79	10	8.71	8.18
Depreciation	6.38	7.86	7.86	10	11	15	15	15
Profit Before Tax	25	15	20	33	17	9.85	26	23
Tax %	29.69	30.58	30.72	22.70	31.43	35.74	28.47	29.07
Net Profit	18	10	14	25	11	6.33	19	16
EPS in Rs	—	31.87	44.81	79.61	30.51	30.03	66.52	61.85
Dividend Payout %	2.54	0.00	3.35	1.79	3.96	4.99	2.26	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3.02	3.02	3.02	3.02	3.02	3.02	3.02
Reserves	103	113	126	149	166	174	194
Borrowings	40	59	65	80	100	101	86
Other Liabilities	124	78	108	125	126	113	107
Total Liabilities	270	253	302	357	395	391	390
Fixed Assets	118	124	130	142	228	223	232
CWIP	3.29	16	38	51	0.85	6.00	0.40
Investments	0.95	0.04	0.04	0.04	0.04	0.04	0.04
Other Assets	148	113	134	163	166	161	158
Total Assets	270	253	302	357	395	391	390

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	30	15	35	-11	15	24	34
Cash from Investing Activity	-44	-27	-26	-7.14	-31	-18	-15
Cash from Financing Activity	15	12	-2.55	11	17	-6.56	-19
Net Cash Flow	1.35	-0.03	6.39	-7.55	0.29	-0.71	-0.07

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
NECLIFE	21.20	471 Cr	—	0.66	0.00	-17.19	-12.07	-19.92
ALBERTDAVD	747.60	429 Cr	—	1.09	0.66	-3.83	-3.33	-2.83
HALEOSLABS	1389.20	422 Cr	22.59	2.05	0.11	9.06	12.31	4.86
MEDICO	49.83	418 Cr	36.74	6.25	0.00	16.97	20.65	8.26
AMANTA	104.00	406 Cr	29.07	1.93	0.00	6.64	11.47	2.73
FABCLEAN	302.00	377 Cr	28.54	4.00	0.65	12.57	13.83	7.53
VALIANTLAB	66.82	360 Cr	71.32	1.14	0.00	1.60	1.50	1.19

Overview

Detailed Summary

Originally incorporated as a real estate private limited company in 2006, SMS Lifesciences has undergone several transformations, including demergers and acquisitions.

The company holds significant recognition as an export house since 1997, indicating expertise in global pharmaceutical supply chains.

With three multi-product facilities and a research center, SMS Lifesciences engages in contract manufacturing and research assignments for an international clientele.

A strategic demerger in 2017 positioned the company to leverage semi-regulated units, enhancing its manufacturing capabilities and international market reach.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

Market Cap

422 Cr

Volatility

High Risk

P/E Ratio

22.6

Industry P/E

30.8

PEG Ratio

0.1

P/B Ratio

2.1

52W High

1,680.00

52W Low

956.05

Sales CAGR

12.67%

-0.96%

5.44%

10Y

—

Profit CAGR

195.89%

-5.57%

18.50%

10Y

—

ROE

TTM

9.06%

8.87%

10.58%

10Y

10.92%

ROCE

TTM

12.31%

13.04%

14.43%

10Y

15.01%